NIH-funded research NIH-funded research

Transforming smoking cessation care in cancer treatment

Official title: Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care

Funded at University of Wisconsin-Madison · NIH-11397545 · Data updated 2026-11-12

A cancer center project helps doctors reliably help patients quit smoking during cancer care using electronic health records and proven quitting strategies.

More Smoking research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startAugust 1, 2015
Project endAugust 31, 2029
Funding year2026
Award (this year)$933,000
NIH project number5R35CA197573-12
Project IDNIH-11397545 on NIH RePORTER

Who could benefit from this research

Could help

Adult cancer patients who currently smoke or have recently quit but are at risk of relapse.

Less likely to help

Patients with cancers or care settings where smoking cessation is not applicable or where participation would interfere with standard treatment.

What this research studies

This grant focuses on making smoking cessation a standard part of cancer treatment for patients who smoke. It builds on years of work to use electronic health records to prompt, track, and tailor quit-support in oncology settings. The goal is to identify practical ways to increase how often quitting help is offered, how it’s delivered, and how well it works for diverse patients. The project aims to measure reach, cost, equity, and effectiveness of the quit-cessation approach within cancer care.

Why it matters

Potential benefit: If successful, more cancer patients who smoke will receive effective quitting support, potentially improving cancer outcomes and overall health.

How similar studies have gone: Past work in primary care shows that EHR-guided quitting support increases quit rates; applying this to oncology is promising but requires cancer-specific evaluation.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Fiore, Michael C — University of Wisconsin-Madison
  • Study coordinator: Fiore, Michael C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.